Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
VYN-201 by VYNE Therapeutics for Vitiligo: Likelihood of Approval
VYN-201 is under clinical development by VYNE Therapeutics and currently in Phase II for Vitiligo. According to GlobalData, Phase II...